|Podcasts|June 29, 2022
The Right Partner to Advance Your Molecule From Gene to Commercialization – The Right Step to Advance Your Molecule
Author(s)Samsung Biologics
Samsung Biologics is responding to industry challenges with various development projects and services that improve overall timelines and efficiencies when manufacturing new medicines.
- Advantages of outsourcing development projects to CDMOs,
- Preventing challenges and starting the development process quickly, and
- Choosing a CMO partner with a highly optimized cell line platform.
Related Content
Trending on Pharmaceutical Technology
1
What the McKesson-Precision Medicine Deal Signals for Trial Sponsors
2
GSK's Jemperli Rectal Cancer Filing Signals Biologics Capacity Shift
3
From Detection to Prediction: Modern Analytical Approaches for Nitrosamine Risk
4
3D Printing Revolutionizing Tissue Engineering and Regenerative Medicine in Europe
5